Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases

Acta Haematologica

Volumn 119, Issue 2, 2008, Pages 98-103

  Nifontova, Irina ^a   Svinareva, Daria ^a   Petrova, Tatiana ^a   Drize, Nina ^a  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

Author keywords

Cytostatic medicines; Fibroblastic colony forming unit; Hematopoietic microenvironment; Mesenchymal stem cells

Indexed keywords

BORTEZOMIB; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DISEASE; CELL COUNT; CELL DIFFERENTIATION; CLINICAL PRACTICE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FIBROBLAST; HEMATOPOIESIS; KIDNEY CAPSULE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; SENSITIVITY ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; BORONIC ACIDS; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; FIBROBLASTS; MESENCHYMAL STEM CELLS; METHOTREXATE; MICE; MICE, INBRED STRAINS; PYRAZINES; STROMAL CELLS;

EID: 42549132252     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120440     Document Type: Article

References (31)

1. Chertkov JL, Gurevitch OA: Hematopoietic Stem Cell and Its Microenvironment, ed 1. Moscow, Meditzina, 1984.
2. Owen M: Marrow stromal stem cells. J Cell Sci Suppl 1988;10:63-76.
3. Caplan AI, Bruder SP: Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-264.
4. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A: Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395.
5. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP: Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-247.
6. Chertkov JL, Gurevitch OA: Self-maintenance ability and kinetics of haemopoietic stroma precursors. Cell Tissue Kinet 1980;13:535-541.
7. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403.
8. Kuznetsov S, Gehron RP: Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int 1996;59:265-270.
9. Chertkov JL, Gurevitch OA, Udalov GA: Role of bone marrow stroma in hemopoietic stem cell regulation. Exp Hematol 1980;8:770-778.
10. Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G: Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997;20:465-471.
11. Mayani H, Guilbert LJ, Janowska-Wieczorek A: Functional characterization of fibroblastic cells in long-term marrow cultures from patients with acute myelogenous leukemia. Leukemia 1993;7:1564-1569.
12. Katsuno M, Hirata J, Kaneko S, Nishimura J, Motomura S, Ibayashi H: Serial studies of bone marrow-derived fibroblastoid colony-forming cells and granulocyte/macrophage precursor cells in patients with acute leukemia. Acta Haematol 1986;76:185-191.
13. Nagao T, Yamauchi K, Komatsuda M, Noguchi K, Shimizu M, Yonekura S, Nozaki H: Inhibition of human bone marrow fibroblast colony formation by leukemic cells. Blood 1983;62:1261-1265.
14. Ben-Ishay Z, Prindull G, Sharon S, Borenstein A: Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia: correlation with CFU-C and CFU-D. Leuk Res 1985;9:1059-1067.
15. Nara N, Jinnai I, Imai Y, Bessho M, Hirashima K: Reduction of granulocyte-macrophage progenitor cells (CFU-C) and fibroblastoid colony-forming units (CFU-F) by leukemic cells in human and murine leukemia. Acta Haematol 1984;72:171-180.
16. Castro-Malaspina H, Gay RE, Jhanwar SC, Hamilton JA, Chiarieri DR, Meyers PA, Gay S, Moore MA: Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 1982;59:1046-1054.
17. Hirata J, Takahira H, Kaneko S, Nishimura J, Nawata H: Bone marrow stromal cells in myeloproliferative disorders. Acta Haematol 1989;82:35-39.
18. Hirata J, Katsuno M, Kaneko S, Umemura T, Nishimura J, Motomura S, Ibayashi H: Clinical significance of human bone marrow stromal cell colonies in acute leukemias. Leuk Res 1986;10:1441-1445.
19. Novitzky N, Kruger W, Mohamed R: Cryopreservation of the bone marrow from patients with acute myeloid leukaemia leads to functional abnormalities. Eur J Haematol 1999;62:83-89.
20. Wathen LM, DeGowin RL, Gibson DP, Knapp SA: Residual injury to the hemopoietic microenvironment following sequential radiation and busulfan. Int J Radiat Oncol Biol Phys 1982;8:1315-1322.
21. Da WM, Ma DD, Biggs JC: Studies of hemopoietic stromal fibroblastic colonies in patients undergoing bone marrow transplantation. Exp Hematol 1986;14:266-270.
22. Momotuk K, Gerasimova L, Savchenko V, Kulikov S, Mendeleeva L, Lubimova L: Influence of different conditioning regimens on stroma precursors. Acute Leukemias V 1996:345-349.
23. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846.
24. Drize NI, Ershler MA, Chertkov IL: Radiation-induced hemopoietic cell growth factor: detection in a culture. Bull Exp Biol Med 2001;132:1213-1215.
25. Han ZC, Briere J, Parent D, Abgrall JF, Sensebe L: Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders. J Biol Regul Homeost Agents 1988;2:119-124.
26. Sun K, Wilkins DE, Anver MR, Sayers TJ, Panoskaltsis-Mortari A, Blazar BR, Welniak LA, Murphy WJ: Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity. Blood 2005;106:3293-3299.
27. Goldberg AL, Rock K: Not just research tools - proteasome inhibitors offer therapeutic promise. Nat Med 2002;8:338-340.
28. Chervontseva AM, Romanov I, Savchenko VG: Effect of cytarabine on expression of cell adhesion molecules and on endothelium-leukocyte interaction in vitro. Ter Arkh 2006;78:67-72.
29. Weissman IL, Anderson DJ, Gage F: Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001;17:387-403.
30. Mukherjee S, Raje N, Patel C, Vallet S, Aronson J, Chhetri S, Mitsiades C, Hideshima T, Anderson K, Scadden D: Bortezomib induces proliferation of mesenchymal progenitor cells and promotes differentiation towards osteoblastic lineage (abstract 88). Blood 2006;108:30.
31. Drize NI, Ershler MA, Chertkov IL: Radiation-induced hemopoietic cell growth factor: detection in a culture. Bull Exp Biol Med 2001;132:1213-1215.